
Naloxone moves OTC: Will broader access curb opioid overdose deaths?
The FDA has approved an over-the-counter naloxone nasal spray, aiming to increase accessibility and reduce opioid overdose fatalities.
Pain's Enduring Role in Functional Decline for Cancer Survivors
Pain significantly contributes to functional decline in cancer survivors, impacting independence and mobility, according to recent research.
Lawmakers Call for Oversight on Physician-Assisted Suicide in Hospice
Lawmakers express concerns over the increasing availability of physician-assisted suicide for hospice patients, citing potential for coercion and inadequate safeguards.
Low Support, High Fear Hinder Opioid Substitution Withdrawal Success
Patients attempting medically supervised withdrawal from opioid substitution therapy face significant barriers, with fear of withdrawal symptoms and inadequate social support driving high rates of treatment discontinuation.
Dexamethasone Offers No Benefit in Headache After Occipital Nerve Block
Adding dexamethasone to greater occipital nerve blocks does not improve headache intensity or duration, according to recent clinical evidence.